Safety Profile of Apixaban For Peri-Procedural Anticoagulation In Heart Transplant Recipients Undergoing Endomyocardial Biopsy

Endomyocardial biopsy (EMB) is routinely performed for surveillance of allograft rejection following heart transplantation (HTx). HTx recipients who are on anticoagulation are at higher risk for complications such as bleeding at access site, pericardial effusion, and cardiac tamponade. The safety of apixaban for periprocedural anticoagulation in heart transplant recipients undergoing EMB is not well characterized.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Tags: 114 Source Type: research